微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 4.47% | -29.16% | 42.36% | 67/160 | 4.14% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 3.14% | -20.51% | 85.8% | 62/160 | 2.6% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 1.69% | -27.47% | -76.2% | 71/160 | 2.3% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 7.1% | 15.26% | 12.52% | 47/160 | -0.96% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 6.31% | 7.86% | 59.75% | 52/160 | 2.37% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 3.95% | 33% | 69.53% | 54/160 | 1.51% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 2.33% | 36.26% | -62.18% | 53/160 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 6.16% | 0.16% | 5.3% | 67/160 | 0.8% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 5.85% | 6.75% | 96.97% | 58/160 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 2.97% | 2.06% | 73.68% | 70/160 | 2.24% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 1.71% | 21.28% | -72.2% | 68/160 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 6.15% | 25.25% | 12.23% | 70/160 | 0.94% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 5.48% | 20.18% | 88.32% | 75/160 | 4.53% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 2.91% | 40.58% | 106.38% | 83/160 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 1.41% | 13.71% | -71.28% | 85/160 | 2.52% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 4.91% | 9.35% | 7.68% | 86/160 | 3.74% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 4.56% | 2.47% | 120.29% | 76/160 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 2.07% | -11.54% | 66.94% | 86/160 | 4.24% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 1.24% | -1.59% | -72.38% | 65/160 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 4.49% | 11.41% | 0.9% | 91/160 | 2.78% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 4.45% | 4.22% | 90.17% | 75/160 | 7.61% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 2.34% | 0% | 85.71% | 80/160 | 5.05% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 1.26% | -20.75% | -68.73% | 79/160 | 2.46% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 4.03% | -20.36% | -5.62% | 96/160 | 7.09% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 4.27% | -27.38% | 82.48% | 77/160 | 7.26% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 2.34% | -29.52% | 47.17% | 77/160 | 4.65% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 1.59% | -22.82% | -68.58% | 65/160 | 2.55% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 5.06% | -60.19% | -13.95% | 84/160 | 9.66% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 5.88% | -51.72% | 77.11% | 56/160 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 3.32% | -64.15% | 61.17% | 70/160 | 5.59% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 2.06% | 2% | -83.79% | 42/160 | 2.1% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 12.71% | -27.41% | 4.35% | 42/160 | 6.33% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 12.18% | 2% | 31.53% | 17/160 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 9.26% | 2% | -47.12% | 16/160 | 3.53% | 德展健康 | 29.5% | 行业排名> |
| 2015-12-31 | 17.51% | -9.37% | -9.37% | 28/160 | 11.35% | 贝达药业 | 16.78% | 行业排名> |